These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1309 related items for PubMed ID: 17360144

  • 1. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
    Roka F, Mastan P, Binder M, Okamoto I, Mittlboeck M, Horvat R, Pehamberger H, Diem E.
    Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.
    Sabel MS, Griffith K, Sondak VK, Lowe L, Schwartz JL, Cimmino VM, Chang AE, Rees RS, Bradford CR, Johnson TM.
    J Am Coll Surg; 2005 Jul; 201(1):37-47. PubMed ID: 15978442
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma.
    Ghaferi AA, Wong SL, Johnson TM, Lowe L, Chang AE, Cimmino VM, Bradford CR, Rees RS, Sabel MS.
    Ann Surg Oncol; 2009 Nov; 16(11):2978-84. PubMed ID: 19711133
    [Abstract] [Full Text] [Related]

  • 6. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI, Rutkowski P, Michej W.
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [Abstract] [Full Text] [Related]

  • 7. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
    Page AJ, Carlson GW, Delman KA, Murray D, Hestley A, Cohen C.
    Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939
    [Abstract] [Full Text] [Related]

  • 8. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [Abstract] [Full Text] [Related]

  • 9. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse.
    Govindarajan A, Ghazarian DM, McCready DR, Leong WL.
    Ann Surg Oncol; 2007 Feb; 14(2):906-12. PubMed ID: 17136471
    [Abstract] [Full Text] [Related]

  • 10. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
    Rossi CR, De Salvo GL, Bonandini E, Mocellin S, Foletto M, Pasquali S, Pilati P, Lise M, Nitti D, Rizzo E, Montesco MC.
    Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880
    [Abstract] [Full Text] [Related]

  • 11. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S, Duru G, Dalle S, Béatrix O, Balme B, Thomas L.
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [Abstract] [Full Text] [Related]

  • 12. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
    Mays MP, Martin RC, Burton A, Ginter B, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Stromberg AJ, McMasters KM, Scoggins CR.
    Cancer; 2010 Mar 15; 116(6):1535-44. PubMed ID: 20108306
    [Abstract] [Full Text] [Related]

  • 13. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
    Statius Muller MG, van Leeuwen PA, de Lange-De Klerk ES, van Diest PJ, Pijpers R, Ferwerda CC, Vuylsteke RJ, Meijer S.
    Cancer; 2001 Jun 15; 91(12):2401-8. PubMed ID: 11413531
    [Abstract] [Full Text] [Related]

  • 14. Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: a single centre observational cohort study.
    Quaglino P, Ribero S, Osella-Abate S, Macrì L, Grassi M, Caliendo V, Asioli S, Sapino A, Macripò G, Savoia P, Bernengo MG.
    Surg Oncol; 2011 Dec 15; 20(4):259-64. PubMed ID: 21145730
    [Abstract] [Full Text] [Related]

  • 15. Criteria in sentinel lymph nodes of melanoma patients that predict involvement of nonsentinel lymph nodes.
    Satzger I, Völker B, Meier A, Kapp A, Gutzmer R.
    Ann Surg Oncol; 2008 Jun 15; 15(6):1723-32. PubMed ID: 18389323
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ, Rousseau DL, Ross MI, Johnson MM, Lee JE, Mansfield PF, Cormier JN, Prieto VG, Gershenwald JE.
    Cancer; 2006 Dec 01; 107(11):2647-52. PubMed ID: 17063497
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection.
    Rutkowski P, Nowecki ZI, Zurawski Z, Dziewirski W, Nasierowska-Guttmejer A, Switaj T, Ruka W.
    Eur J Cancer; 2006 Jan 01; 42(2):159-64. PubMed ID: 16324835
    [Abstract] [Full Text] [Related]

  • 20. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
    Roka F, Kittler H, Cauzig P, Hoeller C, Hinterhuber G, Wolff K, Pehamberger H, Diem E.
    Br J Cancer; 2005 Feb 28; 92(4):662-7. PubMed ID: 15700039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.